Den Europæiske Union - dansk - EMA (European Medicines Agency)

kyowa kirin holdings b.v. - burosumab - hypophosphatemia, familial; hypophosphatemic rickets, x-linked dominant; osteomalacia - narkotika til behandling af knoglesygdomme - crysvita is indicated for the treatment of x-linked hypophosphataemia, in children and adolescents aged 1 to 17 years with radiographic evidence of bone disease, and in adults. crysvita is indicated for the treatment of fgf23-related hypophosphataemia in tumour-induced osteomalacia associated with phosphaturic mesenchymal tumours that cannot be curatively resected or localised in children and adolescents aged 1 to 17 years and in adults.

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - aluminiumaminoacetat, hydrat, magnesiumhydroxid, tungt - tyggetabletter - 500 mg + 100 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

actavis group ptc ehf. - aluminiumhydroxid-magnesiumcarbonat co-prÆcipitat gel - oral suspension - 150 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

orifarm healthcare a/s - magnesiumhydroxid - filmovertrukne tabletter - 500 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

viatris aps - magnesiumhydroxid - filmovertrukne tabletter - 500 mg

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

meda as - aluminiumhydroxid, magnesiumoxid - oral suspension - 110+40 mg/ml

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

vifor fresenius medical care renal pharma france - calcifediol - depotkapsler, bløde - 30 mikrogram

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

alternova a/s - alfacalcidol - kapsler, bløde - 0,25 mikrogram

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

alternova a/s - alfacalcidol - kapsler, bløde - 0,5 mikrogram

Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

alternova a/s - alfacalcidol - kapsler, bløde - 1 mikrogram